With chronic kidney disease projected to be the fifth leading cause of death by 2040, Nephrologist Dr. Adrian Sawyer is ...

BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering. LifeSci Capital is acting as lead manager and H.C.

Medically reviewed by Mary Choy, PharmD It can be surprising to learn that a medication you’re taking for one condition may ...

BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering. LifeSci Capital is acting as lead manager and H.C.

A Radnor biopharma firm saw its stock price skyrocket after the company posted positive late-stage clinical trial results for ...

Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...

The US Food and Drug Administration (FDA) has approved scPharmaceuticals’ supplemental new drug application (sNDA) for ...

Addison’s disease is a rare condition in which the adrenal glands do not produce enough of the hormones cortisol and ...

HALF a million Brits with deadly high blood pressure could be cured by a transformative new treatment. Doctors from the UK ...

Acute kidney injury (AKI) and vitamin D deficiency have a bi-directional relationship. Patients with sepsis AKI might be helped by vitamin D supplementation.

The activated neurohormones angiotensin II, aldosterone, and norepinephrine promote tubular sodium reabsorption, [11,12,13] thus contributing to rebound sodium retention. Consequently, if a ...